A conformationally restricted analogue of L-glutamate, the (2S,3R,4S) isomer of L-alpha-(carboxycyclopropyl)glycine, activates the NMDA-type receptor more markedly than NMDA in the isolated rat spinal cord
- PMID: 2565750
- DOI: 10.1016/0006-8993(89)90207-2
A conformationally restricted analogue of L-glutamate, the (2S,3R,4S) isomer of L-alpha-(carboxycyclopropyl)glycine, activates the NMDA-type receptor more markedly than NMDA in the isolated rat spinal cord
Abstract
Depolarizing actions of 4 conformationally restricted L-glutamate analogues, (2S,3S,4S) isomer (L-CCG-I), (2S,3R,4R) isomer (L-CCG-II), (2S,3S,4R) isomer (L-CCG-III) and (2S,3R,4S) isomer (L-CCG-IV) of L-alpha-(carboxycyclopropyl)-glycine (L-CCG), were investigated in the isolated rat spinal cord by extracellular recordings of potential changes of motoneurones from the ventral roots, in order to study the interaction between the conformation of glutamate and its receptor subtype. The order of the depolarizing activity was quisqualate greater than L-CCG-IV = kainate greater than NMDA greater than L-CCG-I greater than L-CCG-III greater than L-CCG-II. The depolarization caused by L-CCG-IV was effectively blocked by the NMDA antagonists and Mg2+ ions, while the L-CCG-I response was not affected by these blockers. These results suggest that the NMDA-type receptor is activated by a folded form of L-glutamate.
Similar articles
-
Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord.Br J Pharmacol. 1989 Dec;98(4):1213-24. doi: 10.1111/j.1476-5381.1989.tb12667.x. Br J Pharmacol. 1989. PMID: 2692753 Free PMC article.
-
Changes in preference for receptor subtypes of configurational variants of a glutamate analog: conversion from the NMDA-type to the non-NMDA type.Brain Res. 1991 May 31;550(1):152-6. doi: 10.1016/0006-8993(91)90420-z. Brain Res. 1991. PMID: 1653635
-
2-(Carboxycyclopropyl)glycines: binding, neurotoxicity and induction of intracellular free Ca2+ increase.Eur J Pharmacol. 1992 Feb 11;211(2):195-202. doi: 10.1016/0014-2999(92)90529-d. Eur J Pharmacol. 1992. PMID: 1319341
-
Excitatory amino acids: physiological and pharmacological probes for neuroscience research.Acta Neurobiol Exp (Wars). 1993;53(1):43-51. Acta Neurobiol Exp (Wars). 1993. PMID: 8317271 Review.
-
A metabotropic L-glutamate receptor agonist: pharmacological difference between rat central neurones and crayfish neuromuscular junctions.Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992 Sep;103(1):13-7. doi: 10.1016/0742-8413(92)90220-2. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992. PMID: 1360366 Review.
Cited by
-
A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord.Br J Pharmacol. 1993 Aug;109(4):1169-77. doi: 10.1111/j.1476-5381.1993.tb13745.x. Br J Pharmacol. 1993. PMID: 8401927 Free PMC article.
-
Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord.Br J Pharmacol. 1989 Dec;98(4):1213-24. doi: 10.1111/j.1476-5381.1989.tb12667.x. Br J Pharmacol. 1989. PMID: 2692753 Free PMC article.
-
Glutamate receptor ion channels: structure, regulation, and function.Pharmacol Rev. 2010 Sep;62(3):405-96. doi: 10.1124/pr.109.002451. Pharmacol Rev. 2010. PMID: 20716669 Free PMC article. Review.
-
A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/glycine/ion channel receptor macrocomplex.Neurochem Res. 1990 Feb;15(2):217-30. doi: 10.1007/BF00972212. Neurochem Res. 1990. PMID: 2159127 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources